Cogent Biosciences (COGT) EBIAT (2017 - 2020)
Historic EBIAT for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to -$11.3 million.
- Cogent Biosciences' EBIAT fell 59360.03% to -$11.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$74.8 million, marking a year-over-year decrease of 13500.14%. This contributed to the annual value of -$74.8 million for FY2020, which is 13500.14% down from last year.
- As of Q4 2020, Cogent Biosciences' EBIAT stood at -$11.3 million, which was down 59360.03% from -$50.0 million recorded in Q3 2020.
- In the past 5 years, Cogent Biosciences' EBIAT ranged from a high of $2.3 million in Q4 2019 and a low of -$50.0 million during Q3 2020
- Over the past 4 years, Cogent Biosciences' median EBIAT value was -$8.0 million (recorded in 2018), while the average stood at -$10.4 million.
- Per our database at Business Quant, Cogent Biosciences' EBIAT surged by 12669.07% in 2019 and then tumbled by 59360.03% in 2020.
- Over the past 4 years, Cogent Biosciences' EBIAT (Quarter) stood at -$6.7 million in 2017, then decreased by 28.64% to -$8.6 million in 2018, then skyrocketed by 126.69% to $2.3 million in 2019, then tumbled by 593.6% to -$11.3 million in 2020.
- Its last three reported values are -$11.3 million in Q4 2020, -$50.0 million for Q3 2020, and -$7.4 million during Q2 2020.